150 related articles for article (PubMed ID: 9526953)
1. The molecular markers of hemostatic activation on coronary artery disease.
Ulutin T; Sönmez H; Uçişik N; Süer S; Bayram C; Kökoglu E; Sultuybek G
Thromb Res; 1997 Nov; 88(3):329-32. PubMed ID: 9526953
[TBL] [Abstract][Full Text] [Related]
2. Thrombin generation as an acute effect of cigarette smoking.
Kimura S; Nishinaga M; Ozawa T; Shimada K
Am Heart J; 1994 Jul; 128(1):7-11. PubMed ID: 8017287
[TBL] [Abstract][Full Text] [Related]
3. Plasmatic markers of haemostatic system activation in patients with solid neoplasms.
Sagripanti A; Carpi A; Ferdeghini M; Baicchi U; Grassi B
J Nucl Med Allied Sci; 1990; 34(4):321-32. PubMed ID: 2151044
[No Abstract] [Full Text] [Related]
4. Hemostasis activation markers in acute renal failure.
Stefanidis I; Frank D; Maurin N
Ren Fail; 1998 Jan; 20(1):147-55. PubMed ID: 9509568
[TBL] [Abstract][Full Text] [Related]
5. Heparin-coated cardiopulmonary bypass circuits: hemostatic alterations and postoperative blood loss.
Wagner WR; Johnson PC; Thompson KA; Marrone GC
Ann Thorac Surg; 1994 Sep; 58(3):734-40; discussion 741. PubMed ID: 7944696
[TBL] [Abstract][Full Text] [Related]
6. Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia.
Wada H; Mori Y; Kaneko T; Wakita Y; Nakase T; Minamikawa K; Ohiwa M; Tamaki S; Tanigawa M; Kageyama S
Am J Hematol; 1993 Oct; 44(2):112-6. PubMed ID: 8266915
[TBL] [Abstract][Full Text] [Related]
7. Absence of a prothrombotic state in restenotic patients?
Brack MJ; More RS; Pringle S; Gershlick AH
Coron Artery Dis; 1994 Jun; 5(6):501-6. PubMed ID: 7952409
[TBL] [Abstract][Full Text] [Related]
8. Relationship between flow dynamics in the left atrium and hemostatic abnormalities in patients with nonvalvular atrial fibrillation.
Shinohara H; Fukuda N; Soeki T; Takeichi N; Yui Y; Tamura Y; Oki T
Jpn Heart J; 1998 Nov; 39(6):721-30. PubMed ID: 10089934
[TBL] [Abstract][Full Text] [Related]
9. Hemostasis, platelet function and serotonin in acute and chronic renal failure.
Malyszko J; Malyszko JS; Pawlak D; Pawlak K; Buczko W; Mysliwiec M
Thromb Res; 1996 Sep; 83(5):351-61. PubMed ID: 8873344
[TBL] [Abstract][Full Text] [Related]
10. Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease.
Fujinishi A; Takahara K; Ohba C; Nakashima Y; Kuroiwa A
Angiology; 1997 Jun; 48(6):515-21. PubMed ID: 9194537
[TBL] [Abstract][Full Text] [Related]
11. Hemostatic markers in ischemic stroke of undetermined etiology.
Ince B; Bayram C; Harmanci H; Ulutin T
Thromb Res; 1999 Nov; 96(3):169-74. PubMed ID: 10588458
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: effects on inflammatory, hemostatic, and endothelium-derived parameters.
Suzuki S; Matsuo T; Kobayashi H; Matsuo M; Shimamo C; Koide M; Sakamoto S
Thromb Res; 2000 May; 98(4):269-79. PubMed ID: 10822073
[TBL] [Abstract][Full Text] [Related]
13. The coagulation system is activated in idiopathic cardiomyopathy.
Yamamoto K; Ikeda U; Furuhashi K; Irokawa M; Nakayama T; Shimada K
J Am Coll Cardiol; 1995 Jun; 25(7):1634-40. PubMed ID: 7539015
[TBL] [Abstract][Full Text] [Related]
14. [Lipoprotein(a) and hemostasis activation markers in angina pectoris].
Tsakiris DA; Riesen WF; Marbet GA
Dtsch Med Wochenschr; 1995 Aug; 120(33):1109-13. PubMed ID: 7656834
[TBL] [Abstract][Full Text] [Related]
15. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
Soeki T; Tamura Y; Fukuda N; Ito S
Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
[TBL] [Abstract][Full Text] [Related]
16. Laboratory application of radioimmunoassay in the quantitation of molecular markers of hemostatic activation.
Walenga JM; Fareed J; Hoppensteadt D
Semin Thromb Hemost; 1984 Oct; 10(4):294-305. PubMed ID: 6240117
[No Abstract] [Full Text] [Related]
17. A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever.
Rao AK; Schapira M; Clements ML; Niewiarowski S; Budzynski AZ; Schmaier AH; Harpel PC; Blackwelder WC; Scherrer JR; Sobel E
N Engl J Med; 1988 Apr; 318(16):1021-8. PubMed ID: 2965302
[TBL] [Abstract][Full Text] [Related]
18. [Molecular marker for hemostasis and thrombosis].
Fukutake K; Fujimaki M
Nihon Rinsho; 1989 Apr; 47(4):883-90. PubMed ID: 2664266
[No Abstract] [Full Text] [Related]
19. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
Kario K; Matsuo T
Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
[TBL] [Abstract][Full Text] [Related]
20. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
Tschopl M; Tsakiris DA; Marbet GA; Labs KH; Jäger K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3208-14. PubMed ID: 9409313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
